EyePoint

Performance

About EyePoint

EyePoint is a biopharmaceutical company focused on developing and commercializing therapeutics to treat serious retinal diseases. Its proprietary Durasert E technology enables sustained intraocular delivery to potentially preserve or improve vision, with products and a pipeline including DURAVYU for VEGF-mediated retinal diseases. The company operates in the ophthalmology space with facilities in Massachusetts, USA, and has a history of FDA-approved products through its technology platform. EyePoint is dedicated to advancing innovative retinal therapies to improve patients’ quality of life worldwide.